BiomEdit on the move as first product nears market
BE-101, soon to be known as Optavant, is expected to be commercially available in the third quarter of this year after it receives full licensure from the U.S. Department of Agriculture.
Health Care & Life Sciences
Indiana’s rural hospitals struggle with finances, workforce needs
Rural hospitals in Indiana are facing a crisis that could lead to more health deserts across the state, hospital leaders say.
IU School of Medicine names Emory University veteran as new dean
Dr. Scott D. Boden will succeed Dr. Jay Hess, one of the longest-serving medical school deans in the country.
Lilly stock hits high after CVS Caremark restores Zepbound coverage, adds Foundayo
CVS Caremark will add Foundayo coverage on June 1 and resume covering Zepbound on Oct. 1.
Lilly’s experimental obesity drug shows huge weight-loss results in trial
The Indianapolis-based drugmaker said some trial participants saw a level of weight loss similar to what patients experience after bariatric surgery.
Lilly spending nearly $4B to acquire three vaccine developers
The Indianapolis drugmaker is purchasing Curevo Inc., LimmaTech Biologics AG and Vaccine Co. Inc. to expand its research and development efforts in infectious disease.
Lilly goes on $21B buying spree to build drug pipeline
Deal after deal, Eli Lilly and Co. is using the fruits of its success from developing blockbuster GLP-1 medicines to prepare for its next chapter and build a bridge over a looming patent cliff.
Health care summit uses IMS to draw together leaders from across sector
Leaders of the technology company Hc1 planned a small conference that used the appeal of the upcoming Indianapolis 500 to bring together health care leaders from around the country for a few days.
IPS students earn health care credentials before college
At Crispus Attucks High School, students have many career-prep options through the school’s health care pathways program.
Elanco’s newest medication enters $1.3B US itchy-dog market
The Indianapolis-based company has announced the phased launch of Befrena, a monoclonal antibody injection for treating canine allergic and atopic dermatitis.
Statewide health care collaboration to put focus on education, research, training
The Crossroads Academic Medical Institute, or CAMI, will connect universities, health systems and clinical training sites.
Leaders hope name for Indiana’s biosciences ecosystem will help state share its story
The name BioHeartland was created to give Indiana “a more cohesive and unified way to share the state’s story with investors, companies, researchers and talent around the world,” officials said.
Riley patient is first in Indiana to receive gene therapy for blood condition
Beta thalassemia major, also known as Cooley’s anemia and transfusion-dependent beta thalassemia, causes the body’s red blood cells to produce less hemoglobin than usual.
Lilly announces $50M contribution to UNICEF USA for children’s health
The Indianapolis-based drugmaker will work to support UNICEF’s efforts to strengthen primary health care systems to prevent, detect and manage noncommunicable diseases in children and adolescents.
Lilly CEO David Ricks keeps eye on future while company celebrates history
The Indianapolis-based drugmaker is marking 150 years since Col. Eli Lilly founded his company on May 10, 1876.
Corteva to keep its headquarters in Indianapolis post-split
Corteva, which is planning to split into two publicly traded companies later this year, announced Tuesday that the crop protection part of its business will continue to be based in Indianapolis.
Food partnership, life sciences speaker series unveiled at Lilly’s 150th anniversary event
Former Indianapolis Colts quarterback Peyton Manning emceed the event, which took place before about 500 attendees at the new Lilly Event Center in downtown Indianapolis.
Corteva still mulling post-split headquarters decisions
Indianapolis-based agricultural giant Corteva, which plans to separate into two independent companies, said it hasn’t yet decided where the companies will be based.
Lilly announces additional $4.5B investment at LEAP District manufacturing site
Lilly’s latest commitment at the LEAP District brings the company’s total investment there since 2022 to $18 billion.
Corteva announces name of new seed and genetics company
In October, Corteva’s board of directors unanimously approved a plan to separate the company’s crop protection business and its seed business into two independent companies.